# Hubble Therapeutics, LLC — Form D

Hubble Therapeutics, LLC of HANOVER, NH, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-21. The offering totals $11.1M, of which $9.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-10-21
- Form: D
- Accession: 0002038883-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.1M
- Amount sold: $9.8M
- Remaining: $1.3M
- Investors: 17
- Date of first sale: 2024-10-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-527330

## Issuer

- Name: Hubble Therapeutics, LLC
- CIK: 0002038883
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 35 SOUTH MAIN STREET, HANOVER, NH, 03755
- Phone: (617) 780-2375

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Sam Goldberger | Director | Hanover, NH |
| Greg Keenan | Director | Hanover, NH |
| Jeff Sabados | Director | Hanover, NH |
| Jeff Sabados | Executive Officer | Hanover, NH |

## More

- [CIK 2038883 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2038883&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002038883-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.